Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Syrian government, Kurdish-led SDF agree integration deal
Trump warns Britain on China ties as Starmer hails progress in Beijing
Israel releases 15 Palestinian bodies as truce deal shifts to next phase
WHO sees low risk of Nipah virus spreading beyond India
